Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

NCT06066216 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

OTHER_GOV

Sponsor class

Conditions

Endometrial Cancer
Endometrial Adenocarcinoma

Interventions

DRUG: Cadonilimab
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Paclitaxel

Sponsor

Fujian Cancer Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]